Product NDC: | 67425-002 |
Proprietary Name: | VITRASE |
Non Proprietary Name: | hyaluronidase, ovine |
Active Ingredient(s): | 200 [USP'U]/mL & nbsp; hyaluronidase, ovine |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67425-002 |
Labeler Name: | ISTA Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021640 |
Marketing Category: | NDA |
Start Marketing Date: | 20050201 |
Package NDC: | 67425-002-10 |
Package Description: | 2 mL in 1 VIAL, GLASS (67425-002-10) |
NDC Code | 67425-002-10 |
Proprietary Name | VITRASE |
Package Description | 2 mL in 1 VIAL, GLASS (67425-002-10) |
Product NDC | 67425-002 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | hyaluronidase, ovine |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20050201 |
Marketing Category Name | NDA |
Labeler Name | ISTA Pharmaceuticals, Inc. |
Substance Name | HYALURONIDASE, OVINE |
Strength Number | 200 |
Strength Unit | [USP'U]/mL |
Pharmaceutical Classes | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |